Tango Therapeutics Highlights Breakthroughs in Cancer Treatment

TipRanksJan 13 21:28

Cantor Fitzgerald Reiterates Overweight on Tango Therapeuticsto Overweight

BenzingaDec 5, 2024 21:37

Tango Therapeutics Analyst Ratings

BenzingaDec 5, 2024 21:35 · Ratings

Express News | Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 3, 2024 20:00

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango TherapeuticsDec 3, 2024 13:00

Tango Therapeutics Granted FDA Orphan Designation Status For "Small Molecule Inhibitor of PRMT5 (Protein Arginine Methyl Transferase 5)" Treatment Of Pancreatic Cancer

BenzingaNov 27, 2024 22:59